These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6540863)

  • 1. [124 cases of hemolytic diseases in newborn infants other than ABO and Rhesus D observed in the Blood Transfusion Center of Lyon between 1970 and 1982].
    Monestier M; Rigal D; Meyer F; Juron-Dupraz F
    Pediatrie; 1984 Mar; 39(2):93-100. PubMed ID: 6540863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pregnant Rhesus negative Nigerian woman.
    Kotila TR; Odukogbe AA; Okunlola MA; Olayemi O; Obisesan KA
    Niger Postgrad Med J; 2005 Dec; 12(4):305-7. PubMed ID: 16380744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic disease of the newborn in monozygotic twins caused by anti-c alloantibodies of the rhesus system].
    Gligorović VN; Gligorović S
    Bilt Hematol Transfuz; 1980; 8(1):83-9. PubMed ID: 6802130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
    Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
    Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn due to immunologic (ABO incompatibility excluded) and non-immunologic causes].
    Gerbasi M; Cutillo S; Albeggiani A; Balsamo V; La Grutta A; Mollica F; Priolisi A
    Minerva Pediatr; 1967 Sep; 19(36):1670-7. PubMed ID: 5629555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic and therapeutic proceedings in pregnancies with blood group incompatibility: A retrospective analysis over 30 years].
    Müller T; Hofmann J; Kristen P; Dietl J
    Z Geburtshilfe Neonatol; 2002; 206(5):182-6. PubMed ID: 12395291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the early diagnosis of the Rhesus caused hemolytic disease of newborn].
    Berge H; Thierbach V
    Z Arztl Fortbild (Jena); 1968 Jan; 62(2):126-31. PubMed ID: 5727601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perinatal hemolytic disease. Part 1: physiopathology].
    Wirthner D; Hohlfeld P; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Mar; 27(2):135-43. PubMed ID: 9599759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohematology.
    Virella G; Spivey MA
    Immunol Ser; 1993; 58():361-78. PubMed ID: 8424983
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhesus D genotyping in amniotic fluid.
    Müller TH; Gran S; Lammers I; Schunter F
    Beitr Infusionsther Transfusionsmed; 1996; 33():1-6. PubMed ID: 8865931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.